amikacin has been researched along with Infective Endocarditis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cui, Y; Guo, P; Guo, X; Shao, S | 1 |
| Kimura, S; Kitazawa, T; Koga, I; Makita, E; Matsunaga, N; Okugawa, S; Ota, Y; Seo, K; Yoshino, Y | 1 |
| Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Le Conte, P; Le Floch, R; Le Gallou, F; Potel, G; Xiong, YQ; Zhou, XY | 1 |
| Carbon, C; Farinotti, R; Goldstein, F; Gutmann, L; Mainardi, JL; Mohler, J; Zhou, XY | 1 |
| Carbon, C; Caulin, E; Collatz, E; Coutrot, A | 1 |
| Acartürk, E; Akgül, F; Paydaş, S | 1 |
1 review(s) available for amikacin and Infective Endocarditis
| Article | Year |
|---|---|
Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: case report and review of literature.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; Endocarditis; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Lupus Erythematosus, Systemic; Methylobacteriaceae; Piperacillin, Tazobactam Drug Combination | 2019 |
5 other study(ies) available for amikacin and Infective Endocarditis
| Article | Year |
|---|---|
Infective endocarditis due to Enterobacter cloacae resistant to third- and fourth-generation cephalosporins.
Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Endocarditis; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Male; Meropenem; Thienamycins; Treatment Outcome | 2015 |
Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or both.
Topics: Amikacin; Animals; Aortic Valve; beta-Lactamases; Ceftazidime; Drug Administration Schedule; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis; Female; Heart Valve Diseases; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sulbactam | 1995 |
Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l
Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Female; Gentamicins; Klebsiella pneumoniae; Mutation; Rabbits | 1994 |
Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro.
Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Microbial; Endocarditis; Female; Genes, Bacterial; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Rabbits | 1996 |
Large atrial septal aneurysm and delayed improvement of renal failure due to nephrotoxic drugs (and hemodialysis) in a diabetic patient.
Topics: Acute Kidney Injury; Amikacin; Anti-Bacterial Agents; Coronary Aneurysm; Diabetes Complications; Diabetes Mellitus; Endocarditis; Female; Heart Septal Defects, Atrial; Humans; Middle Aged; Time Factors; Ultrasonography; Vancomycin | 2002 |